Y Intercept Hong Kong Ltd Takes Position in Azenta, Inc. (NASDAQ:AZTA)

Y Intercept Hong Kong Ltd purchased a new stake in shares of Azenta, Inc. (NASDAQ:AZTA) during the 4th quarter, Holdings Channel reports. The fund purchased 21,610 shares of the company’s stock, valued at approximately $1,080,000.

Several other hedge funds have also added to or reduced their stakes in the company. State Street Corp raised its holdings in Azenta by 0.4% during the 3rd quarter. State Street Corp now owns 1,686,993 shares of the company’s stock worth $81,718,000 after purchasing an additional 6,398 shares during the last quarter. Conestoga Capital Advisors LLC grew its position in shares of Azenta by 65.0% during the 4th quarter. Conestoga Capital Advisors LLC now owns 1,577,881 shares of the company’s stock worth $78,894,000 after buying an additional 621,830 shares during the period. Allspring Global Investments Holdings LLC raised its stake in shares of Azenta by 1.4% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,317,385 shares of the company’s stock worth $65,922,000 after buying an additional 18,529 shares during the last quarter. Royce & Associates LP lifted its holdings in Azenta by 7.8% in the third quarter. Royce & Associates LP now owns 739,977 shares of the company’s stock valued at $35,844,000 after buying an additional 53,584 shares during the period. Finally, Systematic Financial Management LP boosted its stake in Azenta by 8.7% in the third quarter. Systematic Financial Management LP now owns 434,597 shares of the company’s stock valued at $21,052,000 after acquiring an additional 34,849 shares during the last quarter. Institutional investors own 99.08% of the company’s stock.

Azenta Stock Performance

AZTA opened at $47.04 on Thursday. Azenta, Inc. has a twelve month low of $38.82 and a twelve month high of $67.77. The firm has a market cap of $2.15 billion, a PE ratio of -15.79 and a beta of 1.47. The firm’s fifty day moving average is $50.43 and its two-hundred day moving average is $47.86.

Azenta (NASDAQ:AZTA) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.08 EPS for the quarter, topping the consensus estimate of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. Equities analysts forecast that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on AZTA. Stephens reissued an “overweight” rating and issued a $60.00 price target on shares of Azenta in a research note on Thursday, January 2nd. Needham & Company LLC upped their price objective on Azenta from $55.00 to $59.00 and gave the company a “buy” rating in a report on Thursday, February 6th. Finally, Evercore ISI raised their target price on Azenta from $50.00 to $52.00 and gave the stock an “in-line” rating in a report on Thursday, February 6th.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.